1. Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
   Kamila Raziyeva et al, 2022, Biomedicines CrossRef
2. The role of erythropoietin in the regulation of cardiac tolerance to impact of ischemia and reperfusion
   G. Z. Sufianova et al, 2023, The Siberian Journal of Clinical and Experimental Medicine CrossRef
3. Toll-like receptors in cardiac hypertrophy
   Yanan Zhang et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
4. The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
   Zuzana Tóthová et al, 2021, International Journal of Molecular Sciences CrossRef
5. A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
   Konstantinos I. Papadopoulos et al, 2022, Human Cell CrossRef
6. Reynoutrin Improves Ischemic Heart Failure in Rats Via Targeting S100A1
   Wenkai Yang et al, 2021, Frontiers in Pharmacology CrossRef
7. Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways
   Marawan A. Elbaset et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
8. Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4
   Zheng Xiao et al, 2020, Frontiers in Cardiovascular Medicine CrossRef
9. Beauty and the beast: host microRNA-155 versus SARS-CoV-2
   K. I. Papadopoulos et al, 2023, Human Cell CrossRef